免疫蛋白诊断测试市场规模、份额、成长分析、按测试、按应用、按技术、按最终用途、按分销管道、按地区 - 按行业预测，2024-2031 年

2022年，免疫蛋白诊断测试的全球市场规模为90亿美元，从2023年的96.7亿美元成长到2031年的172.6亿美元，在预测期（2024-2031年）预计将以复合年增长率增长。

在感染疾病和慢性病患病率上升以及人们对早期疾病检测重要性的认识不断提高的推动下，全球免疫蛋白诊断测试市场正在显着增长。重大技术进步，特别是酵素结合免疫吸附检测法（ELISA）和化学冷光免疫检测等诊断技术的进步，显着提高了基于蛋白质的诊断的准确性和效率。人口老化和医疗保健支出的增加进一步推动了这种扩张。然而，成本限制和严格的监管标准等潜在障碍可能会阻碍市场进步。总体而言，对准确、快速诊断工具不断增长的需求正在推动有效疾病管理和明智治疗决策所需的市场动力。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析

免疫蛋白诊断测试市场规模：按测试和复合年增长率（2024-2031）

• 市场概况
• 补体系统蛋白诊断测试
• 免费轻链诊断测试
• 结合球蛋白诊断测试
• 免疫球蛋白诊断测试
• 前白蛋白诊断测试
• C反应蛋白（CRP）诊断测试

免疫蛋白诊断测试市场规模：按应用和复合年增长率（2024-2031）

• 市场概况
• 传染病检查
• 肿瘤检查
• 内分泌检查
• 毒性试验
• 过敏测试
• 自体免疫疾病检测

免疫蛋白诊断测试市场规模：依技术及复合年增长率（2024-2031）

• 市场概况
• 免疫检测
• 酵素免疫分析法
• 化学冷光分析
• 萤光测定
• 免疫比浊法
• 免疫蛋白电泳

免疫蛋白诊断测试市场规模：依最终用途及复合年增长率（2024-2031）

• 市场概况
• 医院和诊所
• 诊断实验室
• 其他的

免疫蛋白诊断测试市场规模：按分销管道和复合年增长率（2024-2031）

• 市场概况
• 直接竞标
• 零售

免疫蛋白诊断测试市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（USA）
• Eurofins Scientific（Luxembourg）
• Qiagen NV（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• DiaSorin SpA（Italy）
• Bio-Rad Laboratories, Inc.（USA）
• Sekisui Medical Corporation（Japan）
• Ortho Clinical Diagnostics（USA）
• Beckman Coulter, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Alere Inc.（USA）
• Quest Diagnostics Incorporated（USA）
• LabCorp（USA）
• BioMerieux SA（France）
• ARUP Laboratories（USA）
• MSD（Merck & Co., Inc.）（USA）

结论和建议

Global Immunoprotein Diagnostic Testing Market size was valued at USD 9.0 billion in 2022 and is poised to grow from USD 9.67 billion in 2023 to USD 17.26 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The global immunoprotein diagnostic testing market is witnessing remarkable growth, propelled by the rising prevalence of infectious and chronic diseases alongside enhanced awareness of the importance of early disease detection. Key technological advancements, particularly in diagnostic methodologies like enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays, have significantly improved the accuracy and efficiency of protein-based diagnostics. The expansion is further supported by an aging population and rising healthcare spending. Nonetheless, potential barriers such as cost constraints and stringent regulatory standards could hinder market progress. Overall, the increasing demand for precise and rapid diagnostic tools is driving market momentum, essential for effective disease management and informed therapeutic decision-making.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunoprotein Diagnostic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunoprotein Diagnostic Testing Market Segmental Analysis

Global Immunoprotein Diagnostic Testing Market is segmented by test, application, technology, end use, distribution channel and region. Based on test, the market is segmented into complement system proteins diagnostic tests, free light chain diagnostic tests, haptoglobin diagnostic tests, immunoglobulin diagnostic tests, prealbumin diagnostic tests and c-reactive protein (CRP) diagnostic tests. Based on application, the market is segmented into infectious disease testing, oncology testing, endocrine testing, toxicology testing, allergy testing and autoimmune disease testing. Based on technology, the market is segmented into radioimmunoassay, enzyme based immunoassay, chemiluminescence assay, immunofluorescence assay, immunoturbidity assay and immunoprotein electrophoresis. Based on end use, the market is segmented into hospitals and clinics, diagnostic laboratories and others. Based on distribution channel, the market is segmented into direct tender and retail sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunoprotein Diagnostic Testing Market

A significant driver of the global immunoprotein diagnostic testing market is the rising incidence of chronic and infectious diseases, which is intensifying the need for precise and prompt diagnostic solutions. Immunoprotein testing is essential for the detection of various conditions, including cancer, autoimmune disorders, and infectious diseases. Moreover, increased awareness surrounding the importance of early disease identification, coupled with advancements in diagnostic technologies, is additionally propelling the growth of this market. As healthcare professionals prioritize timely interventions and accurate assessments, the demand for immunoprotein diagnostic tests continues to surge, further reinforcing the market's expansion.

Restraints in the Global Immunoprotein Diagnostic Testing Market

One of the critical challenges facing the Global Immunoprotein Diagnostic Testing market is the intricate and costly process involved in developing and implementing these tests. Creating reliable and specific immunoprotein diagnostic tests demands extensive research, development, and validation, which can be both time-consuming and resource-intensive. Additionally, the high costs associated with these tests can limit their accessibility, particularly in resource-constrained healthcare environments, thus hindering their broader adoption. This financial barrier not only affects the market's growth potential but also restricts the availability of advanced diagnostic solutions to various segments of the population, ultimately impacting overall market expansion.

Market Trends of the Global Immunoprotein Diagnostic Testing Market

The global immunoprotein diagnostic testing market is experiencing substantial growth, driven by a surge in the incidence of infectious and chronic diseases necessitating precise diagnostic solutions. Innovations in technology, particularly multiplex immunoassay platforms and point-of-care testing, are enhancing the speed and accuracy of diagnostics, fueling market expansion. The rising emphasis on personalized medicine and advancing biomarker research is bolstering the uptake of immunoprotein tests, as tailored therapies become more prevalent. Furthermore, strategic partnerships between industry leaders and research entities are fostering innovation and refining testing methodologies, positioning the market for robust growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Immunoprotein Diagnostic Testing Market Size by Test & CAGR (2024-2031)

• Market Overview
• Complement System Proteins Diagnostic Tests
• Free Light Chain Diagnostic Tests
• Haptoglobin Diagnostic Tests
• Immunoglobulin Diagnostic Tests
• Prealbumin Diagnostic Tests
• C-Reactive Protein (Crp) Diagnostic Tests

Global Immunoprotein Diagnostic Testing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Infectious Disease Testing
• Oncology Testing
• Endocrine Testing
• Toxicology Testing
• Allergy Testing
• Autoimmune Disease Testing

Global Immunoprotein Diagnostic Testing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Radioimmunoassay
• Enzyme Based Immunoassay
• Chemiluminescence Assay
• Immunofluorescence Assay
• Immunoturbidity Assay
• Immunoprotein Electrophoresis

Global Immunoprotein Diagnostic Testing Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Others

Global Immunoprotein Diagnostic Testing Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Direct Tender
• Retail Sales

Global Immunoprotein Diagnostic Testing Market Size & CAGR (2024-2031)

• North America (Test, Application, Technology, End Use, Distribution Channel)
  • USA
  • Canada
• Europe (Test, Application, Technology, End Use, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test, Application, Technology, End Use, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test, Application, Technology, End Use, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test, Application, Technology, End Use, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Medical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co., Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations